2023 PCE Oncology Spring Conferences – Solid Tumors

Review the latest evidence-based strategies for contemporary care of your patients with solid tumors from PCE’s 2023 Spring Oncology Conference. This complimentary CE/CME program is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology.

Coming soon: On-demand webcasts and expert commentaries
Available now: Downloadable slidesets  

Share

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE)

Supporters

Supported by educational grants from AstraZeneca, Exelixis, Inc., Merck Sharp & Dohme LLC., Novartis Pharmaceuticals Corporation, and Seagen.

AstraZeneca

Exelixis, Inc.

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Seagen